TENX | Tenax TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$1.84
+$0.04 (+2.22%)

Tenax Therapeutics (TENX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $1.84 vs 50 $1.84 / 200 $9.93
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Aug 2026 ยท projected 7 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $1.79 vs 50 $10.26 / 200 $16.78
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $1.84 vs 50 $1.76 / 200 $6.74
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Aug 2026 ยท projected 6 bars out

Cross history

20
crosses on record since 2020
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Aug 2026Death steepdaily7 bars outโ€”
13 Aug 2026Death4-hour6 bars outโ€”
10 Jul 2026Golden4-hour20 bars outNot tested
13 May 2026Death4-hour30 bars outNot tested
22 Sep 2025Golden moderatedaily19 bars outNot tested

About TENX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmicro

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.